Even though EMPD cells commonly were short of better predictors which can reflect tumor response to immune checkpoint inhibitors, such as high PD-L1/L2 expression and microsatellite instability-high status, this does not represent that immune checkpoint inhibitors will elicit a poor anti-tumor effect in all EMPD cases (14). This evidence concerns the gene CD274 and extramammary Paget disease.